Qi Yafeng, Yan Jingnan, Huang Xixi, Jiang Xiaodan, Li Rongrong, Wan Jiayi, Li Yangyang, Miao Zhiming, Song Zhongyang, Liu Yongqi, Zhang Liying, Zhang Zhiming
Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, China.
Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, China.
Pharmacol Res. 2025 Jun;216:107788. doi: 10.1016/j.phrs.2025.107788. Epub 2025 May 23.
Chemotherapy resistance and immunosuppression are major causes of tumor treatment failure. The polarization state of tumor-associated macrophages (TAMs) is a central regulatory hub for both processes. Traditional Chinese medicine (TCM) has the characteristics of multi-component, multi-target, and multi-pathway. It regulating M1/M2 polarization is promising due to the high plasticity of TAMs. This review comprehensively explores the anti-tumor effects of TCM active components through multiple targets such as metabolic reprogramming. The mechanism includes regulating TAM's polarization, reversing chemotherapy resistance, and modulating immunosuppression. Furthermore, we also summarize the synergistic effects of TCM multi-component and the exploration of mechanisms promoted by new technologies. While most studies are still in the preclinical stage, these insights highlight the potential of TCM as a cancer treatment and highlight avenues for future research and clinical application to improve patient outcomes.
化疗耐药和免疫抑制是肿瘤治疗失败的主要原因。肿瘤相关巨噬细胞(TAM)的极化状态是这两个过程的核心调控枢纽。中药具有多成分、多靶点、多途径的特点。由于TAM具有高度可塑性,调节其M1/M2极化具有广阔前景。本综述通过代谢重编程等多个靶点全面探讨了中药活性成分的抗肿瘤作用。其机制包括调节TAM的极化、逆转化疗耐药和调节免疫抑制。此外,我们还总结了中药多成分的协同作用以及新技术推动的机制探索。虽然大多数研究仍处于临床前阶段,但这些见解凸显了中药作为癌症治疗方法的潜力,并突出了未来研究和临床应用以改善患者预后的途径。